Top Tech Startups in South Bay in 2024

IonPath is a Stanford University spin-out with a vision to transform clinical pathology and tumor imaging, a $10B+ market, with the company's novel, highly multi-parametric imaging technology, Multiplexed Ion Beam Imaging (MIBI). IonPath's MIBI is a step-change improvement over the current leading tumor imaging method, immunohistochemistry (IHC). MIBI enables researchers, pathologists, and clinicians to quantitatively analyze and visually display the complex interactions among cancer tumor cells, proteins, antibodies, T-cells, and other relevant features on cells' surfaces and interiors. Understanding these biological players and their interactions should substantially improve cancer research and drug discovery, produce novel diagnostics, and transform the study of disease mechanisms such as cancer ("pathology"). IonPath will develop and commercialize services, instruments, reagents, and ultimately diagnostic tests based on MIBI technology.

We are an institutional investment management company investing capital on behalf of institutional investors, family offices, and high-net worth individuals. Our experienced senior teams provide precision, stability and loyalty to our investors and business partners.

At Fuel AI, we connect users, known as Bounty Hunters, with AI companies, referred to as AI Builders, to create and utilize high-quality data. Bounty Hunters get paid to capture valuable data, while AI Builders can easily access first-party data from users to train their models and drive innovation.